Results 211 to 220 of about 5,123,013 (349)
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou +5 more
wiley +1 more source
Mind the gap: addressing missing person time when estimating outcome incidence in longitudinal data. [PDF]
Rudolph JE +7 more
europepmc +1 more source
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
Rationalizing Patterns in the Cation Ordering, Geometric Distortion, and Electronic Properties of a Class of I-V-VI2 Chalcogenide Semiconductors. [PDF]
Flanagin G, Berger RF.
europepmc +1 more source
Closing achievement gaps with a utility-value intervention: Disentangling race and social class.
J. Harackiewicz +4 more
semanticscholar +1 more source
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan +9 more
wiley +1 more source
Innovative Assistive Technologies for Tetraplegia: A Narrative Review of Systematic and Emerging Evidence. [PDF]
Desideri L +3 more
europepmc +1 more source
Addressing critical gaps in the treatment of eating disorders
A. Kazdin +2 more
semanticscholar +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source

